CV Information
BAHARUDIN BIN ABDULLAH PROFESOR DR. BAHARUDIN BIN ABDULLAH
Grant's Name,"Project's Title" (Research Period)(Role)[Sponsorship]
1 FUNDAMENTAL RESEARCH GRANT SCHEME (FRGS), "ELUCIDATING THE INVOLVEMENT OF PERIOSTIN IN THE REGULATION OF INFLAMMATORY MARKER AND IMMUNE CELL PHENOTYPES IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS" (01.09.2019 - 31.08.2022) (Principal)
[ KEMENTERIAN PENDIDIKAN MALAYSIA ] - Source: eR&I
2 , "FUNCTIONAL STUDIES AND INVESTIGATION ON CANDIDATES GENES IMPLICATED IN FUNDAMENTAL MOLECULAR PATHWAY IN THE PATHOGENESIS OF NPC." (31.10.2019 - 31.10.2019)
[ RUI ] - Source: HCMSv3
3 , "ELUCIDATING THE INVOLVEMENT OF PERIOSTIN IN THE REGULATION OF INFLAMMATORY MARKER AND IMMUNE CELL PHENOTYPES IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS" (01.09.2019 - 31.08.2022)
[ FRGS 2019 ] - Source: HCMSv3
4 , "EVALUATION OF VISUALLY INDUCED MOTION SICKNESS FROM 3D VIEWING USING NEUROIMAGING AND PROCESSING TECHNIQUES( A JOINT RESEARCH COLLABORATION WITH UNIVERSITI TEKNOLOGI PETRONAS,TRONOH, PERAK). 23RD APRIL 2012." (23.04.2012 - 31.12.2012) (06)
[ Universiti Teknologi Petronas,Tronoh, Perak ] - Source: HCMSv3
5 , "A PHASE 2, RANDOMIZED CONTROLLED TRIAL OF FOSCAN MEDIATED PHOTODYNAMIC THERAPY VERSUS BRACHYTHERAPY IN PATIENTS WITH RECURRENT OR PERSISTENT NASOPHARYNGEAL CARCINOMA." (23.05.2008 - 30.11.2008) (01)
[ Clinical Research Centre, K.Lumpur and Netherlands Cancer Institute. ] - Source: HCMSv3
6 , "AN OPEN LABELED, MULTICENTRE, RANDOMIZED PHASE 2 TRIAL OF COMBINATION GEMCITABINE AND CARBOPLATIN CHEMOTHERAPY IN PATIENTS WITH METASTATIC OR RECURRENT NASOPHARYNGEAL CARCINOMA." (01.01.2008 - 31.08.2008) (01)
[ Clinical Research Centre, K.Lumpur ] - Source: HCMSv3
7 , "REGISTRY TO EVALUATE THE BURDEN OF DISEASE IN VERTIGO ( REVERT )." (01.01.1900 - 01.01.1900) (01)
[ Solvay Pharma ] - Source: HCMSv3
8 , "A THREE MONTHS OBSERVATIONAL STUDY IN PATIENTS SUFFERING FROM RECURRENT PERIPHERAL VESTIBULAR VERTIGO TO ASSESS THE EFFECT OF BETAHISTINE 48 MG/DAY ON QUALITY OF LIFE AND DIZZINESS SYMPTOMS." (01.01.1900 - 01.01.1900) (01)
[ Solvay Pharma ] - Source: HCMSv3